First, examination of our RNA-sequencing data revealed that of the 14 known HATs, the EP300 (KAT3B) and KAT2B transcripts showed uniformly enhanced expression in radiated tumor cells at both 2 and 7-days post-treatment. This evidence concerns the gene EP300 and neoplasm.